In recent years, Orchid researchers have significantly advanced understanding of male cancers. This page summarises their research achievements.
We would like to thank all our researchers for the valuable work that they have done to help men with male cancer.
Penile Cancer
Better understanding the molecular mechanisms of penile cancer. Their work has shown which tumours are related to the Human Papilloma Virus (HPV) and which tumours are more likely to spread and need early treatment.
Testicular Cancer
Showing which tumours require chemotherapy and which tumours do not.
Discovering a new set of benign tumours which do not need treatment.
The introduction of the single shot carboplatin regime following surgery instead of the more toxic radiotherapy as the standard treatment for this stage of testicular cancer.
Discovery of a damaged gene, ZDHHC14, in testicular and prostate cancer.
Discovery that testicular cancer is a greater risk for people with HIV.
New, highly successful treatments for aggressive testicular cancers, contributing to the high survival rate for this type of cancer.
Collecting drug resistant cases of testicular cancer from previous clinical trials, in collaboration between the Medical Research Council Clinical Trials Unit.
Prostate Cancer
Treatment using chemotherapy in hormone resistant patients, enabling intermittent hormone therapy to be reintroduced.
Identifying different genomic changes in prostate cancer between Chinese and Western patients and research into genetic risk factors.
Identifying which cancers do not spread throughout the body, enabling many more men to be treated with active surveillance.
Conducting new research into advanced tumours to show which need more intense treatment.
Finding that circulating tumour cells (CTCs) can be used as a non-invasive way to diagnose prostate cancer, especially aggressive prostate cancers needing immediate treatment.
Developing a circulating prostate cancer prognosis biomarker using megakaryocytes, cells that produce blood platelets. A patent has been awarded for this work which will help scientists to understand how prostate cancer progresses within the body.
We need regular funding so that we can continue to maintain The Robert Lane Tissue Bank to fund further research. We would be so grateful for any support you can give us.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
